And then there were 8: Fre­se­nius nabs the lat­est Hu­mi­ra biosim­i­lar ap­proval

An­tic­i­pa­tion is build­ing as the US pre­pares for an on­slaught of biosim­i­lars com­pet­ing with Ab­b­Vie’s megablock­buster Hu­mi­ra in the com­ing months.

Fre­se­nius Kabi said this …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.